Description

Itraconazole is a member of the antifungal drug family. It is applied externally (to the skin and nails) to treat specific kinds of fungal infections that occur both inside (within the body).

Both HIV-positive and non-HIV-positive people can benefit from the treatment of fungal infections with itraconazole.

The goal of using aqueous technology to develop itraconazole pellets is to replicate SPORANOX’s dissolving profile without the need for an organic solvent.

The produced product is similar to the innovator in terms of the marketed product’s dissolving profile.

We do provide development services in the event that a modified formulation, dosage, or strength is needed.

Provide a full technical package for registrations in all markets that are regulated or partially regulated.